Cargando…
Are We Underestimating Efficacy and Cost-Efficacy of Population Lung Cancer Computed Tomography Screening?
Autor principal: | Grannis, Frederic W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513554/ https://www.ncbi.nlm.nih.gov/pubmed/36176485 http://dx.doi.org/10.1016/j.jtocrr.2022.100383 |
Ejemplares similares
-
Cost-effectiveness of computed tomography lung cancer screening
por: Reich, Jerome M
Publicado: (2009) -
Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening
por: Castleberry, A W, et al.
Publicado: (2009) -
Are we underestimating the lifelong benefits of therapy for obstructive sleep apnea?
por: Berman, Alec M, et al.
Publicado: (2016) -
The societal cost of Huntington's disease: are we underestimating the burden?
por: Jones, C., et al.
Publicado: (2016) -
Waiting for orthopedic surgery — are we underestimating the impacts on people with advanced osteoarthritis?
por: Ackerman, I.N.
Publicado: (2022)